Stocks Higher as In...
Health Care: Drugs
Amarin Corporation PLC (AMRN: NASDAQ)
$6.60 -0.02 | -0.30%
06/18/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 260.24M | 116.60M | 31.44M | 52.26M |
| Receivables | 0.00 | 0.00 | 0.00 | 1.19M |
| Inventories | 21.26M | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 3.25M | 1.84M | 1.06M | 2.60M |
| Total Current Assets | 285.69M | 118.97M | 33.11M | 56.05M |
| Property, Plant & Equipment, Gross | 1.17M | 608.00K | 203.00K | 1.23M |
| Accumulated Depreciation & Depletion | 356.00K | 176.00K | 115.00K | 1.10M |
| Property, Plant & Equipment, Net | 811.00K | 432.00K | 88.00K | 128.00K |
| Intangibles | 11.36M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 4.95M | 2.24M | 0.00 | 17.00K |
| Total Non-Current Assets | 25.16M | 7.41M | 2.25M | 145.00K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 310.86M | 126.38M | 35.37M | 56.20M |
| Accounts Payable | 17.46M | 4.42M | 4.45M | 2.46M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 3.15M | 0.00 | 0.00 | 398.00K |
| Total Current Liabilities | 25.20M | 8.45M | 7.58M | 6.69M |
| Long Term Debt | 219.40M | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 70.25M | 123.12M | 230.07M | 902.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 289.65M | 123.89M | 230.16M | 902.00K |
| Total Liabilities | 314.85M | 132.34M | 237.73M | 7.60M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -4.00M | -5.96M | -202.37M | 48.60M |
| Common Par | 124.60M | 113.32M | 90.46M | 83.93M |
| Additional Paid In Capital | 619.27M | 449.39M | 206.72M | 188.34M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | -2.57M |
| Retained Earnings | -747.64M | -568.46M | -499.33M | -271.30M |
| Treasury Stock | -217.00K | -217.00K | -217.00K | -217.00K |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 50.43M |
| Total Capitalization | 215.41M | -5.96M | -202.37M | 48.60M |
| Total Equity | -4.00M | -5.96M | -202.37M | 48.60M |
| Total Liabilities & Stock Equity | 310.86M | 126.38M | 35.37M | 56.20M |
| Total Common Shares Outstanding | 150.34M | 135.81M | 106.84M | 98.80M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 40.16K | 40.16K | 20.08K | 0.00 |
| Basic Weighted Shares Outstanding | 144.02M | 130.25M | 100.24M | 42.42M |
| Diluted Weighted Shares Outstanding | 144.02M | 130.25M | 100.24M | 42.42M |
| Number of Employees | 111 | 31 | 16 | 20 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AMRN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Useralexr685
- ContributorDrugs Facing FDA Approval i...
- ContributorHigh Volume Technicals for ...
- ContributorBreakout Stocks Of The Week...
- UserHassan Portfolio
- Contributor4 Drug Stocks Facing FDA Ap...
- UserLividog
- ContributorStocks Rising On Unusual Vo...
- UserPharma
Latest AMRN Headlines from TheStreet
- As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel 06.06.13 | 11:06 am
- June 14th Options Now Available For Amarin Corp Plc (AMRN) 06.06.13 | 10:06 am
- Amarin To Present At The Jefferies 2013 Global Healthcare Conference 05.30.13 | 04:05 pm
- June 7th Options Now Available For Amarin Corp Plc (AMRN) 05.30.13 | 11:05 am
- Amarin Announces Additional Effects Of Vascepa(R) On Lipoprotein Particle Concentration From The ANCHOR Study Presented At The National Lipid Association 2013 Annual Scientific Sessions 05.30.13 | 06:05 am
- Doc Claims SummerStreet's Amarin Report Is Inaccurate 05.29.13 | 07:05 am
- Big Pharma Wants Fish Oil After All, But At Half Amarin's Selling Price 05.28.13 | 09:05 am
- Biotech Stock Mailbag: Amarin, MannKind, Palatin 05.24.13 | 07:05 am
- Amarin Announces Notification Of Patent Allowance For U.S. Application 13/417,899 Related To Combination Product Of Vascepa(R) And Statin Therapy 05.22.13 | 06:05 am
- Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE) 05.21.13 | 10:05 am
Press Releases for AMRN
- Amarin To Present At The Deutsche Bank 26th Annual Healthcare Conference - PR Newswire 04.26.11 | 08:04 am
- Amarin's AMR101 Phase 3 ANCHOR Trial Meets All Primary And Secondary Endpoints With Statistically Significant Reductions In Triglycerides At Both 4 Gram And 2 Gram Doses And Statistically Significant Decrease In LDL-C - PR Newswire 04.18.11 | 02:04 am
- Phase 3 MARINE Trial Data To Be Presented In May At The National Lipid Association 2011 Annual Scientific Sessions - PR Newswire 04.05.11 | 08:04 am
- Amarin To Present At The 10th Annual Needham Healthcare Conference - PR Newswire 03.31.11 | 07:03 am
Partner Headlines for AMRN
- Will Amarin’s Positive Test Result Impress These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.08.13 | 01:04 pm
- Will Amarin’s Positive Test Result Impress These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.08.13 | 01:04 pm
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha 03.05.13 | 09:03 am
- Stock Watch Tuesday, 8 January - Seeking Alpha 01.08.13 | 09:01 am
- Stock Watch Wednesday, 2 January - Seeking Alpha 01.02.13 | 08:01 am
- 5 Medical Stock Losers From Last Week With High Short Ratios - Seeking Alpha 12.22.12 | 06:12 am
- Pre-Market Most Active for Dec 7, 2012 : BAC, QQQ, NOK, AMRN, VNTV, AVGO, MEMP, AAPL, FB, SAN, C, FCX - NASDAQ 12.07.12 | 01:12 pm
- After Hours Most Active for Dec 6, 2012 : MMR, BX, QQQ, S, AMRN, EPHC, BAC, EMC, AIG, DISH, LINTA, ORCL - NASDAQ 12.06.12 | 09:12 pm
